342 related articles for article (PubMed ID: 33461143)
1. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells.
Wang Z; Sun X; Feng Y; Liu X; Zhou L; Sui H; Ji Q; E Q; Chen J; Wu L; Li Q
Anticancer Drugs; 2017 Mar; 28(3):281-288. PubMed ID: 27997436
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell.
Li CH; Ding H; Shi JL; Huang B; Ding H; Lin HG; Zeng JC; Zhao Y; Luo GQ
J Tradit Chin Med; 2021 Jun; 41(3):367-375. PubMed ID: 34114393
[TBL] [Abstract][Full Text] [Related]
4. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract][Full Text] [Related]
5. Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer.
Sui H; Zhu HR; Wu J; Nikitin AY; Cai JF; Fan ZZ; Li Q
Chin J Integr Med; 2014 Aug; 20(8):610-7. PubMed ID: 23543356
[TBL] [Abstract][Full Text] [Related]
6. Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells.
Wu M; Jiang M; Dong T; Xu L; Lv J; Xue M; Huang M
Asian Pac J Cancer Prev; 2020 May; 21(5):1269-1274. PubMed ID: 32458632
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
8. Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.
Sui H; Zhou LH; Zhang YL; Huang JP; Liu X; Ji Q; Fu XL; Wen HT; Chen ZS; Deng WL; Zhu HR; Li Q
J Cell Biochem; 2016 Jun; 117(6):1471-81. PubMed ID: 26590365
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line.
Zhang C; He LJ; Ye HZ; Liu DF; Zhu YB; Miao DD; Zhang SP; Chen YY; Jia YW; Shen J; Liu XP
Mol Med Rep; 2018 Dec; 18(6):5409-5416. PubMed ID: 30365132
[TBL] [Abstract][Full Text] [Related]
10. Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.
Xu X; Zhang X; Zhang Y; Yang L; Liu Y; Huang S; Lu L; Kong L; Li Z; Guo Q; Zhao L
Sci Rep; 2017 Feb; 7():39950. PubMed ID: 28150717
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
Gao R; Fang C; Xu J; Tan H; Li P; Ma L
Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
[TBL] [Abstract][Full Text] [Related]
12. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
[TBL] [Abstract][Full Text] [Related]
13. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway.
Wu JJ; Zhu YF; Guo ZZ; Lou YM; He SG; Guan Y; Zhu LJ; Liu ZQ; Lu LL; Liu L
Phytomedicine; 2018 May; 44():87-97. PubMed ID: 29277460
[TBL] [Abstract][Full Text] [Related]
14. Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.
Yang R; Song C; Chen J; Zhou L; Jiang X; Cao X; Sun Y; Zhang Q
Phytomedicine; 2020 Apr; 69():153211. PubMed ID: 32259676
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.
Jiang L; Wang P; Sun YJ; Wu YJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):265. PubMed ID: 31215501
[TBL] [Abstract][Full Text] [Related]
16. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
17. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
[TBL] [Abstract][Full Text] [Related]
18. Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway.
Luo Y; Lu S; Dong X; Xu L; Sun G; Sun X
Apoptosis; 2017 Aug; 22(8):1013-1024. PubMed ID: 28612103
[TBL] [Abstract][Full Text] [Related]
19. (2R,3R)Dihydromyricetin inhibits osteoclastogenesis and bone loss through scavenging LPS-induced oxidative stress and NF-κB and MAPKs pathways activating.
Zhang X; Li X; Fang J; Hou X; Fang H; Guo F; Li F; Chen A; Huang S
J Cell Biochem; 2018 Nov; 119(11):8981-8995. PubMed ID: 30076654
[TBL] [Abstract][Full Text] [Related]
20. [Reversal of chemoresistance to vincristine in gastric cancer cells by NF-kappaB inhibitor].
Wang W; Luo HS
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):335-8. PubMed ID: 16117894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]